ACG Wealth’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-41,971
Closed -$2.59M 247
2015
Q4
$2.59M Buy
41,971
+3,455
+9% +$218K 0.58% 51
2015
Q3
$2.43M Buy
38,516
+1,044
+3% +$74.5K 0.65% 46
2015
Q2
$2.74M Buy
37,472
+7
+0% +$506 0.69% 42
2015
Q1
$2.45M Buy
37,465
+1,175
+3% +$78.1K 0.65% 50
2014
Q4
$2.36M Sell
36,290
-357
-1% -$23K 0.64% 49
2014
Q3
$2.2M Sell
36,647
-34,402
-48% -$2.25M 0.62% 55
2014
Q2
$4.92M Buy
71,049
+36,155
+104% +$2.34M 0.93% 34
2014
Q1
$2.28M Sell
34,894
-14,442
-29% -$940K 0.68% 42
2013
Q4
$3.06M Buy
49,336
+15,191
+44% +$880K 0.78% 41
2013
Q3
$1.83M Sell
34,145
-800
-2% -$41.2K 0.76% 50
2013
Q2
$1.59M Buy
+34,945
New +$1.51M 0.62% 52

Other funds holding STJ

ACG Wealth's STJ Position: Q1 2016 in Review

ACG Wealth sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 41,971 shares — an estimated $2.59M sold.

ACG Wealth first reported a position in STJ in Q2 2013 and held it in 11 quarters. The position peaked at $4.92M in Q2 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • ACG Wealth reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
  • ACG Wealth sold 41,971 St Jude Medical shares in Q1 2016, an estimated $2.59M.
  • ACG Wealth first reported a position in St Jude Medical in Q2 2013 and held it in 11 quarters.
  • ACG Wealth's St Jude Medical position peaked at $4.92M in Q2 2014.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on ACG Wealth's 13F filing for Q1 2016, filed 16 May 2016.